Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125520673 | 12552067 | 3 | F | 20160103 | 20160725 | 20160713 | 20160808 | EXP | IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-120081 | RANBAXY | 50.00 | YR | F | Y | 0.00000 | 20160808 | OT | IT | IT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125520673 | 12552067 | 1 | PS | Paracetamol | ACETAMINOPHEN | 1 | Oral | 1000 MG DAILY | Y | U | 76200 | 1000 | MG | ||||||
125520673 | 12552067 | 2 | SS | EXPOSE 100 MG | EPERISONE HYDROCHLORIDE | 1 | Oral | 100 MG DAILY | Y | U | 0 | 100 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125520673 | 12552067 | 1 | Myalgia |
125520673 | 12552067 | 2 | Myalgia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125520673 | 12552067 | OT |
125520673 | 12552067 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125520673 | 12552067 | Drug hypersensitivity | |
125520673 | 12552067 | Dyspnoea | |
125520673 | 12552067 | Paraesthesia | |
125520673 | 12552067 | Urticaria |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125520673 | 12552067 | 1 | 20160101 | 20160103 | 0 | |
125520673 | 12552067 | 2 | 20160101 | 20160103 | 0 |